CELL MEDX CORP. CMXC overview

Carson City, Nevada--(Newsfile Corp. - September 17, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has submitted a premarket notification (510K) to the U.S. Food and Drug Administration (FDA) for the eBalance® Home System and eBalance® Pro System. The eBalance® Pro System and eBalance®...

Carson City, Nevada--(Newsfile Corp. - May 26, 2021) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on May 25, 2021, the Company issued 2,484,500 common shares of the Company (the "Shares") on conversion of $496,900 the Company owed its debt holders under 6% demand notes payable and...

Carson City, Nevada--(Newsfile Corp. - September 24, 2020) - Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, announced today that it has signed an extension agreement with Think Ink Marketing Data & Email Services, Inc. ("Think Ink") to provide public relations services in an effort to increase public...

Carson City, Nevada--(Newsfile Corp. - September 1, 2020) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is happy to announce that in August 2020, Health Canada granted Cell MedX (Canada) Corp., the Company's wholly-owned subsidiary, a Class II Medical Device License for its innovative eBalance Pro System. The...

Carson City, Nevada--(Newsfile Corp. - August 4, 2020) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on July 30, 2020, the Company closed its non-brokered private placement offering (the "Offering") at a price of $0.25 per unit (the "Unit"), by issuing 988,000 Units for total gross...

Carson City, Nevada--(Newsfile Corp. - July 22, 2020) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is happy to announce that on July 17, 2020, Health Canada granted Cell MedX (Canada) Corp., the Company's wholly-owned subsidiary, a Class II Medical Device License for its innovative eBalance Home System. The...

Carson City, Nevada--(Newsfile Corp. - July 7, 2020) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company has filed an application for a Class II Medical Device License for the eBalance Pro System and the eBalance Home System with Health Canada. The applications consisted of the Device License...

Carson City, Nevada--(Newsfile Corp. - June 9, 2020) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that the Company received a Quality Management System - ISO 13485:2016 certificate #MDSAP 716274 for design, development, and manufacture of microcurrent therapeutic devices, specifically the Company's eBalance®...